RCS - Cambridge Cognition - Capital Markets Showcase
RNS Number : 0362PCambridge Cognition Holdings PLC05 June 20205 June 2020
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Capital Markets Showcase
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that it will be hosting a Capital Markets Showcase via Webex on 30 June 2020 at 10am.
The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the Company's product and technology portfolios.
To express interest in attending the event please email: zach.cohen@investor-focus.co.uk
No material new information or update on current trading will be disclosed at the event.
For further information, contact:
Cambridge Cognition Holdings PLC
Matthew Stork, Chief Executive Officer
Nick Walters, Chief Financial Officer
Tel: 012 2381 0700
finnCap Ltd (NOMAD and Joint Broker)
Geoff Nash / Simon Hicks
Alice Lane / Manasa Patil
Tel: 020 7220 0500
(Corporate Finance)
(Corporate Broking)
Dowgate Capital Limited (Joint Broker)
David Poutney / James Serjeant
Tel: 020 3903 7715
IFC Advisory Ltd (Financial PR and IR)
Tim Metcalfe / Graham Herring / Zach Cohen
Tel: 020 3934 6630
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDNRASSEFMLESSELM
Recent news on Cambridge Cognition Holdings
See all newsREG - Cambridge Cognition - Formation of new Scientific Advisory Board
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Cambridge Cognition and ActiGraph Partnership
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Board appointments
Announcement